Platelet-derived factors are also involved in immunomodulation, as is the case with TREM-like transcript 1 (TLT-1) protein, which is higher in platelets from patients with lung cancer and promotes cancer progression via suppression of CD8 T-cells [41]. Here, CD8A is linked to lung carcinoma.